Startup developing HPV vaccine raises $2.75 million

PathoVax plans to initiate Phase 1 clinical trials for its HPV vaccine in the first half of 2020.
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Source Type: news